![Ralf Penner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Ralf Penner first degree
Entity | Entity type | Industry | |
---|---|---|---|
21
| Public Company | Pharmaceuticals: Major | 21 |
Extinct | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ralf Penner via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
DePuy Orthopaedics, Inc.
![]() DePuy Orthopaedics, Inc. Medical SpecialtiesHealth Technology DePuy Orthopaedics, Inc. engages in the design, manufacture, and distribution of orthopedic devices and supplies. Its products are used primarily by orthopedic medical specialists and spinal neurosurgeons in both surgical and non-surgical therapy. The company was founded on December 13, 2016 and is headquartered in Warsaw, IN. | Medical Specialties | Chief Executive Officer | |
CeNeS Pharmaceuticals Plc
![]() CeNeS Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals Plc engages in the discovery and development of drugs. The company was founded by Alan Gilbert Goodman in 1997 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
DSM NV
![]() DSM NV Chemicals: SpecialtyProcess Industries DSM BV engages in the provision of ingredients, expertise, and solutions for plant-based products. It operates through the following segments: Animal Nutrition and Health (ANH); Health, Nutrition, and Care (HNC); Food and Beverage (F and B); and Other. The ANH segment includes developing sustainable animal farming through essential products, performance solutions, and precision services serving the poultry, swine, ruminants, and aquaculture markets. The HNC segment provides health, nutrition, and care solutions for markets such as early life nutrition, dietary supplements, pharma, medical, and personal care. The F and B segment focuses on supporting healthy diets through nutritious, delicious, and sustainable solutions for several market segments including bakery, beverages and brewing, dairy, savory, plant-based alternative proteins, and pet food. The Other segment is involved in corporate activities. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. | Chemicals: Specialty | Corporate Officer/Principal | |
MDXHEALTH SA | Medical Specialties | Director/Board Member | |
ALMIRALL, S.A. | Pharmaceuticals: Major | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
ERGO Group AG
![]() ERGO Group AG Insurance Brokers/ServicesFinance ERGO Group AG engages in the provision of insurance and financial services. Its business units include German, International, and Direct and digital business. The firm offers life insurance, health insurance, legal expenses insurance, property and casualty insurance, travel insurance, pension fund, and financial services. The company was founded on August 1, 1997 and is headquartered in Dusseldorf, Germany. | Insurance Brokers/Services | Director/Board Member | |
KERRY GROUP PLC | Food: Specialty/Candy | Director/Board Member | |
GETINGE AB | Medical Specialties | Corporate Officer/Principal | |
GRONTMIJ | Engineering & Construction | Director/Board Member | |
PROTEOME SCIENCES PLC | Medical Specialties | Chief Executive Officer Director of Finance/CFO | |
OXFORD BIOMEDICA PLC | Biotechnology | Founder Chief Executive Officer | |
MOLOGEN AG | Miscellaneous Commercial Services | Chief Executive Officer | |
CURASAN AG | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing | |
Avlar Ltd.
![]() Avlar Ltd. Investment ManagersFinance Avlar Ltd. (Avlar BioVentures) is a venture capital firm founded in 1999 by Alan Goodman and Daniel Roach. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Chief Executive Officer | |
Grünenthal GmbH
![]() Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer | |
Merckle GmbH
![]() Merckle GmbH Pharmaceuticals: MajorHealth Technology Merckle GmbH engages in the manufacture of pharmaceutical products. It offers specialty and generic medicines, as well as over-the-counter drugs. The firm also provides management services for the group. The company was founded in 1881 and is headquartered in Blaubeuren, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Booz Allen Hamilton, Inc.
![]() Booz Allen Hamilton, Inc. Engineering & ConstructionIndustrial Services Booz Allen Hamilton, Inc. engages in the provision of management and technology consulting services. Its services include consulting, analytics, digital solutions, engineering, cyber security, and product. The company was founded by Edwin G. Booz in 1914 and is headquartered in McLean, VA. | Engineering & Construction | Corporate Officer/Principal | |
Roche Group
![]() Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
Immatics Biotechnologies GmbH
![]() Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member | |
RWTH Aachen University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree Doctorate Degree | |
Vrije Universiteit Amsterdam | College/University | Doctorate Degree | |
University of Bonn | College/University | Doctorate Degree Undergraduate Degree | |
European Federation of Pharmaceutical Industries & Assns
![]() European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
GERRESHEIMER AG | Containers/Packaging | Director/Board Member | |
Strategy&
![]() Strategy& Miscellaneous Commercial ServicesCommercial Services Strategy& engages in the provision of global management consulting services. It serves industries including aerospace and defense; health; oil and gas; technology; automotive; entertainment and media; power and utilities; telecommunications; and transportation. The company was founded in 1914 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Paion Deutschland GmbH
![]() Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Biotechnology | Chief Executive Officer Chief Executive Officer Chief Executive Officer Director/Board Member Chief Executive Officer Chief Executive Officer | |
Trommsdorff GmbH & Co. KG
![]() Trommsdorff GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Trommsdorff GmbH & Co. KG engages in the manufacture, development, and distribution of pharmaceuticals, as well as nutritional and dietary supplements. It also sells medical equipment and devices. The company is headquartered in Alsdorf, Germany. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Humedics GmbH
![]() Humedics GmbH Packaged SoftwareTechnology Services Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany. | Packaged Software | Chairman | |
VITA 34 AG | Biotechnology | Director/Board Member | |
Fachhochschule Düsseldorf | College/University | Corporate Officer/Principal | |
ArjoHuntleigh AB
![]() ArjoHuntleigh AB Medical SpecialtiesHealth Technology ArjoHuntleigh AB manufactures and sells medical devices and solutions for mobility, lifting, and wound care. Its products include floor and ceiling lifters; slings; medical and therapeutic beds; disinfectors; and VTE prevention devices. The company is headquartered in Malmö, Sweden. | Medical Specialties | Chief Executive Officer | |
Rotterdam School of Management | College/University | Masters Business Admin | |
PAION, Inc.
![]() PAION, Inc. Pharmaceuticals: MajorHealth Technology Part of PAION AG, PAION, Inc. is a pharmaceutical manufacturing company. The company is based in Mahwah, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Immatics US, Inc.
![]() Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member | |
Julius Clinical Research BV
![]() Julius Clinical Research BV Miscellaneous Commercial ServicesCommercial Services Julius Clinical Research BV is a scientifically focused CRO that provides end-to-end clinical trial services to pharmaceutical and biotechnology customers, governments, and academia. The private company is based in the Netherlands and was founded in 2008. Julius Clinical's renowned scientific leaders are at the forefront of their fields, which combine with operational excellence and a network of research sites to deliver tailor-made solutions for customers and their clinical trials. The Dutch company has approximately 200 employees and has supported over 130 clinical trials, enrolling more than 200,000 participants in around 40 countries. Julius Clinical has a focus on the therapeutic areas of neurology, renal, cardiometabolic, and infectious diseases. The company uses its unique triangle of science, networks, and operations to provide tailored CRO and SMO services. Martijn Wallert has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Convert Pharmaceuticals SA
![]() Convert Pharmaceuticals SA Miscellaneous Commercial ServicesCommercial Services Convert Pharmaceuticals SA provides preclinical stage drug development services. Its product hypoxia activated prodrug (HAP) is a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. The company was founded by Philippe Lambin, Nicolas Geuens, and Paul Tulcinsky on February 24, 2017 and is headquartered in Liege, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer | |
Bootcamp | Founder | ||
Eusa Pharma Europe Ltd. | President | ||
W. Söhngen GmbH
![]() W. Söhngen GmbH Medical SpecialtiesHealth Technology W. Söhngen GmbH engages in the development, production, and distribution of medical kits. It offers products for wound care as well as first aid and emergency medicine. The company is headquartered in Taunusstein, Germany. | Medical Specialties | Chief Executive Officer | |
Quantum Diamond Technologies, Inc.
![]() Quantum Diamond Technologies, Inc. Information Technology ServicesTechnology Services Quantum Diamond Technologies, Inc. develops and commercializes nanoscale devices. The company is headquartered in Somerville, MA. | Information Technology Services | Director/Board Member | |
Van Eeghen & Co. BV
![]() Van Eeghen & Co. BV Financial ConglomeratesFinance Van Eeghen & Co. BV is an investment company based in Amsterdam, Netherlands. The Dutch company operates as an investment firm. | Financial Conglomerates | Director/Board Member | |
Cognifisense, Inc.
![]() Cognifisense, Inc. Packaged SoftwareTechnology Services Cognifisense, Inc. is a technology company based in Sunnyvale, CA. Cognifisense's core product is virtual reality neuropsychological therapy (VRNT), which is a patented virtual reality-based therapy designed to treat chronic pain. The therapy combines psychological therapies with the immersive power of VR to address the maladaptive neuroplastic changes in the brain that drive chronic pain. The company was founded by Tassilo Baeuerle and Harald F. Stock, with Tassilo Baeuerle serving as CEO since incorporation. | Packaged Software | Founder | |
Intravacc BV
![]() Intravacc BV BiotechnologyHealth Technology Institute for Translational Vaccinology is a Dutch independent company that partners with clients in vaccine development, from discovery to pilot production to clinical studies. The non-profit company is based in Bilthoven, Netherlands. Intravacc designs and creates the best candidate organisms for vaccine strain, looking for the highest immunity, potency, and production yield. The company substantially reduces the risks and costs involved with developing vaccines by bridging the gap between concept and late-stage clinical studies. Intravacc's upstream processing expertise covers both bacterial and cell cultivation as well as virus propagation in reactors ranging from 1l up to 200l. The company's scientists design, develop, and improve vaccine formulations that are suitable for the intended administration route and stable upon storage. | Biotechnology | Director/Board Member |
Statistics
International
Germany | 20 |
United States | 9 |
Netherlands | 8 |
United Kingdom | 7 |
Belgium | 4 |
Sectoral
Health Technology | 23 |
Finance | 7 |
Consumer Services | 7 |
Commercial Services | 6 |
Technology Services | 4 |
Operational
Director/Board Member | 94 |
Chief Executive Officer | 38 |
Corporate Officer/Principal | 38 |
Founder | 19 |
Chairman | 17 |
Most connected contacts
Insiders | |
---|---|
Hans Tanner | 24 |
James Phillips | 24 |
Karin Louise Dorrepaal | 19 |
Irina Antonijevic | 17 |
Harald F. Stock | 17 |
Alan Gilbert Goodman | 15 |
Walter Wenninger | 14 |
Mariola Söhngen | 12 |
Jürgen Beck | 9 |
Michael Schlenk | 8 |
Abdelghani Omari | 8 |
John Dawson | 8 |
Tilmann Bur | 7 |
Jürgen Raths | 7 |
Markus Guilherme Dieken | 6 |
- Stock Market
- Insiders
- Ralf Penner
- Company connections